MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Bioiberica

Bioiberica
Bioiberica is a research based pharmaceutical company focused in the research development, manufacturing and marketing of Glycosaminglicans such as Chondroitin, Heparin, Glucosamine & Hyaluronic Acid.

The company in detail

Profile


Specialized in Joint Health terapeutic area, the company is fully integrated from the origin of the active ingredient to the medicinal product and patient and has an extensive molecular, medical and market knowledge.

Established since 1975, Bioiberica is a privately owned company which has built up a strong research, marketing and manufacturing foundation; the company currently employs over 320 members of staff and has 8 manufacturing plants located in Spain (4), USA, Poland, and Brazil.

Constantly researching in chondroprotection, in terms of current developments Bioiberica has 15 projects of basic research, 3 molecules in pre-clincal status and 2 projects of clinical research under development.

Bioiberica has a strong position as a specialist in Joint Health, being the market leader in Spain and internationally leading research in chondroprotection.

The company offers not only a wide range of chondroprotective drugs for treating osteoarthritis but also a line of dietary supplements for joint ailments. Because Bioiberica understands health from a wide perspective, providing an osteoarthritis holistic approach.

 

Partnering strategy/interests

Bioiberica is looking for partners that distribute either its range of chondroprotective drugs for osteoarthritis, or its range of dietary supplements and OTC products for joint health.

Out-licensing

BIOIBERICA would extend the right to use its CTD dossier for registration of Cartisorb® (Glucosamine Sulfate sachets) as a branded generic drug (to be marketed under Cartisorb® brand name or other brand name) on a local level. More
Alleviates joint discomfort More
For tendon health and recovery More

R&D

To view this information, you must subscribe to PL Intelligence.

Contact details

Mónica Gómez
Product Manager
Joint Care Division

Contact directly

Full contact list

Head office

Bioiberica
Pl. Francesc Macià, 7
Barcelona
08029
Spain

Company figures

Formed: 1975
Number of employees: 320

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us